Hot Flashes
Hormone therapy use higher among midlife active-duty servicewomen, but gaps remain
Use of menopausal hormone therapy among midlife active-duty servicewomen in the U.S. is twice as high as the general population but lower than women veterans, suggesting those who may derive the most benefit from HT are not receiving it.
More focus needed on Black, low-income women to identify, treat common midlife conditions
More than 45% of midlife women are diagnosed with several common conditions in addition to menopausal symptoms and data show Black women and those living in high deprivation areas are disproportionately affected, researchers reported.
Link between fatty liver disease, hot flash severity ‘hard to tease apart’
Midlife women with a metabolic dysfunction-associated steatotic liver disease diagnosis were more likely to report severe or very severe hot flashes, though researchers found no direct link between the two conditions, data show.
FDA adds boxed warning to hot flash drug Veozah due to liver injury risk
The FDA added a boxed warning to highlight known risk for rare but serious liver injury associated with the use of fezolinetant, a nonhormonal medication indicated for treating menopausal hot flashes, according to an agency press release.
Frequent, persistent hot flashes associated with 50% increased risk for diabetes
Women with frequent and persistent hot flashes and night sweats during the menopause transition are at increased risk for developing diabetes compared with women who do not experience vasomotor symptoms, researchers reported.
Making menopause mainstream: A conversation with Monica Christmas, MD, FACOG, MSCP
Interest in menopause and all things related to midlife women’s health continues to grow, and The Menopause Society is expanding to meet the demand.
Top in women's health: Impact of diet, lifestyle on fertility; postmenopausal hot flashes
In a Healio interview exclusive, two experts discussed the roles that diet and lifestyle play in promoting fertility among women seeking to conceive.
FDA accepts new drug application for nonhormonal hot flash drug elinzanetant
The FDA accepted a new drug application for elinzanetant, a nonhormonal treatment for moderate to severe vasomotor symptoms associated with menopause, according to an industry press release.
Poor hot flash documentation in primary care setting leaves many midlife women untreated
Many postmenopausal women self-reported moderate or higher vasomotor symptoms in the primary care setting but remained untreated due to lack of electronic health record documentation, researchers reported.
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
CHICAGO — For menopausal women experiencing disruptive, bothersome hot flashes, some relief may come from visiting a snowy landscape by slipping on a virtual reality headset, according to a speaker.